CDC: U.S. COVID-19 Deaths Could Reach 233,000 by End of October
And, dual coronavirus-flu vaccine to start human trials
Remdesivir Cuts Time to COVID-19 Recovery
However, no significant difference in mortality found between remdesivir and placebo groups
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Manufacturer Prices for Insulin Substantially Higher in the U.S.
Manufacturer prices more than eight times higher in the U.S. than in other high-income countries
DKA Episode May Harm Cognitive Function in Children With T1D
Lower IQ and worse memory seen in children with newly diagnosed type 1 diabetes and single event
American Academy of Otolaryngology-Head and Neck Surgery, Sept. 13-Oct. 25
The 124th American Academy of Otolaryngology-Head and Neck Surgery Foundation Annual Meeting and OTO Experience The annual meeting of the American Academy of...
28 Percent With T1DM Received Remote Care in Pandemic
Most patients found remote appointments useful and planned to have remote appointments in the future
Poll: Medication Management Lacking in Older Adults
Most older adults taking multiple medications have never had a comprehensive medication review
Maker of Antibody Cocktail Trump Took Seeks Emergency Use Authorization
Although effectiveness has not yet been seen in humans, drug has shown promise in treating mild cases of COVID-19
Some Patients Have Increase in Cardiac Events With Azithromycin
Risk for cardiac events higher with azithromycin versus amoxicillin in those using QT-prolonging drugs
